The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C01 | Cardiac therapy | |
| 3 | C01B | Antiarrhythmics, class I and III | |
| 4 | C01BD | Antiarrhythmics, class III |
| Code | Title | |
|---|---|---|
| C01BD01 | Amiodarone | |
| C01BD02 | Bretylium tosilate | |
| C01BD03 | Bunaftine | |
| C01BD04 | Dofetilide | |
| C01BD05 | Ibutilide | |
| C01BD06 | Tedisamil | |
| C01BD07 | Dronedarone |
| Active Ingredient | Description | |
|---|---|---|
| Amiodarone |
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. |
|
| Dronedarone |
Dronedarone is a multichannel blocker inhibiting the potassium currents (including IK(Ach), IKur, IKr, IKs) and thus prolonging cardiac action potential and refractory periods (Class III). It also inhibits the sodium currents (Class Ib) and the calcium currents (Class IV). It non-competitively antagonises adrenergic activities (Class II). |
|
| Ibutilide |
Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CORDARONE X 100 Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| CORDARONE X Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MULTAQ Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
